Synexus(R)’s New Phase IV Clinical Trial Model Increases Number Of Doctors Involved Whilst Cutting Costs And Time

Synexus(R) - the world’s largest multi-national company specialising in the recruitment and running of late-stage clinical trials - is extending the scope of its studies to include Phase IV trials following the recent running of successful Phase IV studies for major pharmaceutical companies.Phase IV trials (Post Marketing Surveillance Trials) allow pharma to monitor the wider use of a new medicine with both patients and doctors after the medicine has received its license.

More: continued here

Filed under: Clinical Trials on May 18th, 2008